Flavonoids As Therapeutics for Myocardial Ischemia-reperfusion Injury: a Comprehensive Review on Preclinical Studies

Overview

Journal Lab Anim Res

Date 2024 Sep 5

PMID 39237965

Authors

Vipin Kumar Verma

Priya Bhardwaj

Vaishali Prajapati

Avantika Bhatia

Sayani Purkait

Dharamvir Singh Arya

Affiliations

Soon will be listed here.

Abstract

Ischemic heart disease is the most prevalent cause of death worldwide affecting both the gender of all age groups. The high mortality rate is due to damage of myocardial tissue that emanates at the time of myocardial ischemia and re-oxygenation, thus averting reperfusion injury is recognized as a potential way to reduce acute cardiac injury and subsequent mortality. Flavonoids are polyphenol derivatives of plant origin and empirical shreds of evidence substantiate their numerous activities such as antioxidant, anti-inflammatory, anti-apoptotic, and anti-thrombotic activity, leading to their role in cardio protection. Recent investigations have unveiled the capacity of flavonoids to impede pivotal regulatory enzymes, signaling molecules, and transcription factors that orchestrate the mediators participating in the inflammatory cascade. The present comprehensive review, dwells on the preclinical studies on the effectiveness of flavonoids from the year 2007 to 2023, for the prevention and therapeutics for myocardial ischemia-reperfusion injury.

References

Huang Q, Tian L, Zhang Y, Qiu Z, Lei S, Xia Z . Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus. Biomed Pharmacother. 2023; 163:114795. DOI: 10.1016/j.biopha.2023.114795. View

Meng L, Ma H, Guo H, Kong Q, Zhang Y . The cardioprotective effect of naringenin against ischemia-reperfusion injury through activation of ATP-sensitive potassium channel in rat. Can J Physiol Pharmacol. 2016; 94(9):973-8. DOI: 10.1139/cjpp-2016-0008. View

Kim J, Jin Y, Kim Y, Rhie S, Kim H, Seo H . Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2008; 84(7-8):227-34. DOI: 10.1016/j.lfs.2008.12.005. View

Zhang J, Zhu L, Li H, Tang Q . Electroacupuncture Pretreatment as a Novel Avenue to Protect Heart against Ischemia and Reperfusion Injury. Evid Based Complement Alternat Med. 2020; 2020:9786482. PMC: 7254080. DOI: 10.1155/2020/9786482. View

Testai L, Martelli A, Marino A, DAntongiovanni V, Ciregia F, Giusti L . The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury. Biochem Pharmacol. 2013; 85(11):1634-43. DOI: 10.1016/j.bcp.2013.03.018. View

Pan Q, Liu Y, Ma W, Kan R, Zhu H, Li D . Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence. Front Cardiovasc Med. 2022; 9:685998. PMC: 9081501. DOI: 10.3389/fcvm.2022.685998. View

Jafari S, Shoghi M, Khazdair M . Pharmacological Effects of Genistein on Cardiovascular Diseases. Evid Based Complement Alternat Med. 2023; 2023:8250219. PMC: 10238142. DOI: 10.1155/2023/8250219. View

Verma V, Malik S, Mutneja E, Sahu A, Bhatia J, Arya D . Attenuation of ROS-mediated myocardial ischemia-reperfusion injury by morin via regulation of RISK/SAPK pathways. Pharmacol Rep. 2020; 72(4):877-889. DOI: 10.1007/s43440-019-00011-2. View

Roth G, Johnson C, Abajobir A, Abd-Allah F, Abera S, Abyu G . Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1):1-25. PMC: 5491406. DOI: 10.1016/j.jacc.2017.04.052. View

10.

Liu K, Wang F, Wang S, Li W, Ye Q . Mangiferin Attenuates Myocardial Ischemia-Reperfusion Injury via MAPK/Nrf-2/HO-1/NF-B and . Oxid Med Cell Longev. 2019; 2019:7285434. PMC: 6535818. DOI: 10.1155/2019/7285434. View

11.

Suchal K, Malik S, Gamad N, Malhotra R, Goyal S, Ojha S . Mangiferin protect myocardial insults through modulation of MAPK/TGF-β pathways. Eur J Pharmacol. 2016; 776:34-43. DOI: 10.1016/j.ejphar.2016.02.055. View

12.

Abe C, Miyazawa T, Miyazawa T . Current Use of Fenton Reaction in Drugs and Food. Molecules. 2022; 27(17). PMC: 9457891. DOI: 10.3390/molecules27175451. View

13.

Li L, Li D, Qu N, Wen W, Huang W . The role of ERK1/2 signaling pathway in coronary microembolization-induced rat myocardial inflammation and injury. Cardiology. 2010; 117(3):207-15. DOI: 10.1159/000321713. View

14.

Prem P, Sivakumar B, Boovarahan S, Kurian G . Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review. Phytomedicine. 2022; 101:154123. DOI: 10.1016/j.phymed.2022.154123. View

15.

Sanchez M, Romero M, Gomez-Guzman M, Tamargo J, Perez-Vizcaino F, Duarte J . Cardiovascular Effects of Flavonoids. Curr Med Chem. 2018; 26(39):6991-7034. DOI: 10.2174/0929867326666181220094721. View

16.

Xiao C, Xia M, Wang J, Zhou X, Lou Y, Tang L . Luteolin Attenuates Cardiac Ischemia/Reperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxid Med Cell Longev. 2019; 2019:2719252. PMC: 6476158. DOI: 10.1155/2019/2719252. View

17.

Liu P, Li J, Liu M, Zhang M, Xue Y, Zhang Y . Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis. Biomed Pharmacother. 2021; 139:111552. DOI: 10.1016/j.biopha.2021.111552. View

18.

Kim D, Ha K, Kwon D, Kim M, Kim H, Chae S . Kaempferol protects ischemia/reperfusion-induced cardiac damage through the regulation of endoplasmic reticulum stress. Immunopharmacol Immunotoxicol. 2008; 30(2):257-70. DOI: 10.1080/08923970701812530. View

19.

Gandhi C, Upaganalawar A, Balaraman R . Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. Free Radic Res. 2009; 43(9):817-27. DOI: 10.1080/10715760903071656. View

20.

Suchal K, Malik S, Gamad N, Malhotra R, Goyal S, Chaudhary U . Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury. Oxid Med Cell Longev. 2016; 2016:7580731. PMC: 4819110. DOI: 10.1155/2016/7580731. View